Jove
Visualize
Contact Us

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

5.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.6K
Structure and Function of Platelets01:18

Structure and Function of Platelets

1.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.1K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

507
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
507
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

663
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
663
Introduction to Hemostasis01:05

Introduction to Hemostasis

7.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.0K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

5.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioinspired Passive Flow Routing to Mitigate Thrombosis in Prosthetic Heart Valves and Cardiovascular Devices.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Revisiting surfactant delivery modalities for ARDS.

Journal of applied physiology (Bethesda, Md. : 1985)·2026
Same author

iPSC-Derived Bronchial Airways-On-Chip for the Assessment of Cytokine Secretion Triggered by Volatile Organic Compounds.

ACS biomaterials science & engineering·2026
Same author

Stent Thrombogenicity is Modulated by Design: Wire Crossings in Braided Stents are Focal Thrombogenic Niches.

Thrombosis and haemostasis·2026
Same author

Fibrin as a thrombin sink: a factor retaining a thrombus in the stillness phase.

Blood·2026
Same author

Transient build-up of a mural thrombus promotes intrathrombus coagulation reactions.

Biophysical journal·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 20, 2025

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

21.6K

A double-edged sword: The complex interplay between engineered nanoparticles and platelets.

Yathreb Asaad1, Danielle Nemcovsky-Amar1, Josué Sznitman1

  • 1Department of Biomedical Engineering Technion-Israel Institute of Technology Haifa Israel.

Bioengineering & Translational Medicine
|July 22, 2024
PubMed
Summary

Nanoparticles (NP) impact blood platelets, influencing their activation or inhibition. Understanding these platelet-NP interactions is vital for safe nanomedicine development and therapeutic applications.

Keywords:
drug carriershemostasisnanoparticlesphysicochemical parametersplateletssystemic deliverythrombosis

More Related Videos

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
11:18

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

15.7K
Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

15.9K

Related Experiment Videos

Last Updated: Jun 20, 2025

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

21.6K
Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
11:18

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

15.7K
Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

15.9K

Area of Science:

  • Nanomedicine
  • Biomaterials Science
  • Hematology

Background:

  • Nanoparticles (NP) are key in nanomedicine for targeted drug delivery.
  • Systemic NP injection leads to direct interactions with blood cells, especially platelets.
  • Platelet response to NP exposure is critical due to potential health outcomes.

Purpose of the Study:

  • To review the effects of various nanoparticle types on platelet function.
  • To highlight physicochemical parameters governing platelet-nanoparticle interactions.
  • To identify knowledge gaps and suggest future research directions in platelet-NP interactions.

Main Methods:

  • Review of existing scientific literature on nanoparticle-platelet interactions.
  • Discussion of polymeric, ceramic, silica, dendrimer, and metallic nanoparticles.
  • Focus on physicochemical properties influencing platelet response.

Main Results:

  • Nanoparticles can either augment hemostasis or inhibit thrombus formation.
  • Physicochemical parameters significantly dictate the effects of nanoparticles on platelets.
  • Diverse NP types exhibit varied impacts on platelet activation and function.

Conclusions:

  • Understanding platelet-nanoparticle interactions is crucial for nanomedicine safety and efficacy.
  • A significant knowledge gap exists, necessitating further investigation.
  • Development of improved research methodologies and guidelines is essential, including biomimetic in vitro models.